Page last updated: 2024-08-17

mepazine and Pancreatic Neoplasms

mepazine has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Betzel, C; Bockhorn, M; Buchholz, A; El Gammal, AT; Graß, JK; Grupp, K; Güngör, C; Hofmann, BT; Izbicki, JR; Kapis, S; Klemp, C; Konczalla, L; Landschulze, D; Lüddeke, J; Meier, C; Nuguid, T; Perez, DR; Püschel, K; Sauter, G; Schumacher, U; Spriestersbach, SL; Steinberg, P; Uzunoglu, FG; Wenzel, N; Wolski, A; Wolters-Eisfeld, G; Yao, D1

Other Studies

1 other study(ies) available for mepazine and Pancreatic Neoplasms

ArticleYear
Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
    International journal of cancer, 2020, 03-15, Volume: 146, Issue:6

    Topics: Animals; Biperiden; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Humans; Mice; Mice, Knockout; Models, Molecular; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; NF-kappa B; Pancreatic Neoplasms; Phenothiazines; Proto-Oncogene Proteins c-rel; Random Allocation; Xenograft Model Antitumor Assays

2020